Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
4,435.00
-55.00 (-1.22%)
Aug 12, 2026, 2:37 PM KST
-52.72% (1Y)
| Market Cap | 104.43B -52.1% |
| Revenue (ttm) | n/a +13,737.3% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 23.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 65,971 |
| Open | 4,495.00 |
| Previous Close | 4,490.00 |
| Day's Range | 4,330.00 - 4,570.00 |
| 52-Week Range | 3,350.00 - 11,520.00 |
| Beta | 0.70 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |